Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.
Saved in:
| Title: | Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Walker JS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Wenzl K; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA., Novak JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Stokes ME; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA., Hopper MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dropik AR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Siminski MS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Bock AM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute/University of Utah, Salt Lake City, UT, USA., Sarangi V; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Ortiz M; Informatics and Predictive Sciences, Celgene Institute for Translational Research Europe (CITRE), Seville, Spain., Stong N; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA., Huang CC; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Maurer MJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Link BK; Division of Hematology, University of Iowa, Iowa City, IA, USA., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., King RL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Nowakowski G; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Cerhan JR; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Gandhi AK; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Novak AJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Novak.Anne@mayo.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Jul 12; Vol. 15 (1), pp. 120. Date of Electronic Publication: 2025 Jul 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40651974 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Walker+JS%22">Walker JS</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Wenzl+K%22">Wenzl K</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Novak+JP%22">Novak JP</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Stokes+ME%22">Stokes ME</searchLink>; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hopper+MA%22">Hopper MA</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Dropik+AR%22">Dropik AR</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Siminski+MS%22">Siminski MS</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Bock+AM%22">Bock AM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute/University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Sarangi+V%22">Sarangi V</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Ortiz+M%22">Ortiz M</searchLink>; Informatics and Predictive Sciences, Celgene Institute for Translational Research Europe (CITRE), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Stong+N%22">Stong N</searchLink>; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Huang+CC%22">Huang CC</searchLink>; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Maurer+MJ%22">Maurer MJ</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Link+BK%22">Link BK</searchLink>; Division of Hematology, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Ansell+SM%22">Ansell SM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Habermann+TM%22">Habermann TM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Witzig+TE%22">Witzig TE</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22King+RL%22">King RL</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Nowakowski+G%22">Nowakowski G</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Cerhan+JR%22">Cerhan JR</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Gandhi+AK%22">Gandhi AK</searchLink>; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Novak+AJ%22">Novak AJ</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Novak.Anne@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Jul 12; Vol. 15 (1), pp. 120. <i>Date of Electronic Publication: </i>2025 Jul 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40651974 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41408-025-01326-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 120 Titles: – TitleFull: Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Walker JS – PersonEntity: Name: NameFull: Wenzl K – PersonEntity: Name: NameFull: Novak JP – PersonEntity: Name: NameFull: Stokes ME – PersonEntity: Name: NameFull: Hopper MA – PersonEntity: Name: NameFull: Dropik AR – PersonEntity: Name: NameFull: Siminski MS – PersonEntity: Name: NameFull: Bock AM – PersonEntity: Name: NameFull: Sarangi V – PersonEntity: Name: NameFull: Ortiz M – PersonEntity: Name: NameFull: Stong N – PersonEntity: Name: NameFull: Huang CC – PersonEntity: Name: NameFull: Maurer MJ – PersonEntity: Name: NameFull: Link BK – PersonEntity: Name: NameFull: Ansell SM – PersonEntity: Name: NameFull: Habermann TM – PersonEntity: Name: NameFull: Witzig TE – PersonEntity: Name: NameFull: King RL – PersonEntity: Name: NameFull: Nowakowski G – PersonEntity: Name: NameFull: Cerhan JR – PersonEntity: Name: NameFull: Gandhi AK – PersonEntity: Name: NameFull: Novak AJ IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 07 Text: 2025 Jul 12 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2044-5385 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Blood cancer journal Type: main |
| ResultId | 1 |
